Get started
Author

Angela J Mehr

Observed names: Angela J. Mehr, Mehr A.J
Observed institution: University of Minnesota
ORCID: 0009-0004-1885-3279
Observed ORCID: 0009-0004-1885-3279
OpenAlex ID: A5076570693
Updated Evidence for COVID-19, RSV, and Influenza Vaccines for 2025-2026
2025 · Jake Scott, Michael S. Abers, et al. · New England Journal of Medicine · 75
PDF
A Research and Development (R&D) roadmap for influenza vaccines: Looking toward the future
2021 · Kristine A. Moore, Julia T. Ostrowsky, et al. · Vaccine · 74
PDF
Measures to prevent and treat Nipah virus disease: research priorities for 2024–29
2024 · Kristine A Moore, Angela J Mehr, et al. · The Lancet Infectious Diseases · 60
Lassa fever research priorities: towards effective medical countermeasures by the end of the decade
2024 · Kristine A Moore, Julia T Ostrowsky, et al. · The Lancet Infectious Diseases · 32
Zika virus vaccines and monoclonal antibodies: a priority agenda for research and development
2025 · Julia T Ostrowsky, Leah C Katzelnick, et al. · The Lancet Infectious Diseases · 29
Zika virus: advancing a priority research agenda for preparedness and response
2025 · Eve M Lackritz, Eve M Lackritz, et al. · The Lancet Infectious Diseases · 26
PDF
A research and development (R&D) roadmap for broadly protective coronavirus vaccines: A pandemic preparedness strategy
2023 · Kristine A. Moore, Tabitha Leighton, et al. · Vaccine · 24
Accomplishments and challenges in developing improved influenza vaccines: An evaluation of three years of progress toward the milestones of the influenza vaccines research and development roadmap
2025 · Julia T. Ostrowsky, Natalie C. Vestin, et al. · Vaccine · 8
Hepatitis B Vaccination at Birth: Safety, Effectiveness, and Public Health Benefit
2026 · Angela K. Ulrich, Derek F. Fleming, et al. · PEDIATRICS · 4
PDF
Influenza response planning for the centers of excellence for influenza research and surveillance: Science preparedness for enhancing global health security
2020 · Kristine A. Moore, Julia T. Ostrowsky, et al. · Influenza and Other Respiratory Viruses · 4
Funding the priorities of the influenza vaccines research and development roadmap: an evaluation of global investment
2025 · Angela K. Ulrich, Lauren Bigalke, et al. · Vaccine · 3
Meeting Report on an Integrated Research Agenda for Mosquito-Borne Arboviruses
2025 · Angela K Ulrich, Nicolina M Moua, et al. · Open Forum Infectious Diseases · 3
PDF
A research and development (R&D) roadmap for broadly protective coronavirus vaccines: A pandemic preparedness strategy
2024 · Rees H.V, Lackritz E.M, et al. · Carolina Digital Repository (University of North Carolina at Chapel Hill) · 1
PDF
Innovation, development, and licensure of improved influenza vaccines: the way forward
2026 · Julia T. Ostrowsky, Bruce G. Gellin, et al. · Vaccine
Trends in funding for coronavirus vaccine research and development: implications for preparedness against future coronavirus threats
2026 · Derek Fleming, Emily Smith, et al. · npj Vaccines
PDF
Works count: 15
Citation count: 343
H-index: 8
I10-index: 7
Year
Topic
Type